Drug recall · July 24, 2019
Gatifloxacin Ophthalmic Solution 0.5% recall
Why: Labeling: Missing label; Product complaints reported missing bottle label.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only, Rx Only, Sterile, 2.5 mL Bottle, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC 68180-435-01.
- Lots / codes
Lot #: H805157, Exp. 05/2020
- Quantity
- 17,238 bottles
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Nationwide in the U.S. and PR.
- Initiated
- July 11, 2019 · Voluntary: Firm initiated
- Classified
- July 17, 2019
- Reported
- July 24, 2019
- Ended
- September 9, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gatifloxacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.